Joshua H. Bilenker, President & CEO at Loxo Oncology, Inc. (LOXO), sold 19,500 shares at $188.28 ($3.6M) on 2018-07-09, disclosed to the SEC on 2018-07-11.
Open-market sale of $3.6M LOXO by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $184.87 | 900 | $166K | 4.6% |
| 2 | $186.38 | 1,500 | $280K | 7.8% |
| 3 | $187.39 | 3,698 | $693K | 19.3% |
| 4 | $187.39 | 3,698 | $693K | 19.3% |
| 5 | $188.28 | 802 | $151K | 4.2% |
| 6 | $188.28 | 802 |
| $151K |
| 4.2% |
| 7 | $189.43 | 300 | $57K | 1.6% |
| 8 | $191.63 | 300 | $57K | 1.6% |
| 9 | $178.19 | 2,200 | $392K | 10.9% |
| 10 | $179.08 | 2,200 | $394K | 11.0% |
| 11 | $180.08 | 1,000 | $180K | 5.0% |
| 12 | $181.21 | 1,300 | $236K | 6.6% |
| 13 | $182.84 | 800 | $146K | 4.1% |
| Total | $184.42 avg | 19,500 | $3.6M | 100% |
| Filing → |
| LOXO | SELL | 2018-11-28 | $2.9M | — | Filing → |
| LOXO | SELL | 2018-10-05 | $5.4M | — | Filing → |
| LOXO | SELL | 2018-09-14 | $5.0M | — | Filing → |